The CV safety of a lower dose of liraglutide (1.8 mg, Victoza, Novo Nordisk) in people with T2D was established in the Liraglutide Effect and Action in Diabetes: Evaluation of CV Outcome Results (LEADER) study, showing a 13% reduction in major CV events over an average of 3.8 years [44]
J Neurochem (2005) 92:798806
In addition to using the patches herself, Morales, like many of the people making content about the efficacy of the patches, is now selling them through TikTok Shop
An FDA program called Medwatch allows for anyone to report side effects of drugs on the market
For acne, lower-dose isotretinoin may be appropriate for patients who: Are highly sensitive to side effects Require prolonged treatment Have difficulty tolerating standard doses For GLP-1 medications, lower dosing within approved ranges may be reasonable if a patient is responding well